Kymera CBO sells 5,000 shares, exercises options
Kymera Therapeutics Chief Business Officer Noah Goodman reported an exercise-and-sell transaction in company stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Kymera Therapeutics Chief Business Officer Noah Goodman reported an exercise-and-sell transaction in company stock. He exercised stock options for 5,000 shares of Common Stock at an exercise price of $21.05 per share, then sold 5,000 shares in two open-market sales at prices of $119.00 and $109.00 per share.
After these transactions, he directly holds 50,195.438 shares of Common Stock and 90,000 stock options. The filing notes that the sales were effected under a pre-arranged Rule 10b5-1 trading plan dated December 10, 2025.
Insider Trade Summary 10b5-1
Exercise and Sale: 5,000 shares ($465K approx. pre-tax spread)
Exercise and Sale
4 txns
Insider
Goodman Noah
Role
Chief Business Officer
Sold
5,000 shs ($570K)
Approx. gross sale proceeds
$570K
Approx. exercise cost
$105K
Approx. pre-tax spread
$465K
Share of Position Sold
9.1%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 5,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,000 | $21.05 | $105K |
| Sale | Common Stock | 2,500 | $109.00 | $273K |
| Sale | Common Stock | 2,500 | $119.00 | $298K |
Holdings After Transaction:
Stock Option (Right to Buy) — 90,000 contracts (Direct);
Common Stock — 50,195.438 shares (Direct)
Holdings Before and After:
Stock Option (Right to Buy), 95,000 to 90,000 contracts (Direct);
Common Stock, 50,195.438 to 50,195.438 shares (Direct)
Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (2)
- F1. These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.
- F2. Twenty-five percent (25%) of the shares underlying this stock option vested on April 8, 2026, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the reporting person's continued employment through each vesting date.
Key Figures
Shares sold at $119: 2,500 shares at $119.00
Shares sold at $109: 2,500 shares at $109.00
Options exercised: 5,000 shares at $21.05
+4 more
7 metrics
Shares sold at $119
2,500 shares at $119.00
Common Stock open-market sale on 2026-06-25
Shares sold at $109
2,500 shares at $109.00
Common Stock open-market sale on 2026-06-25
Options exercised
5,000 shares at $21.05
Stock option exercise into Common Stock
Shares held after
50,195.438 shares
Direct Common Stock ownership after transactions
Options remaining
90,000 stock options
Direct option holdings after reported exercise
Rule 10b5-1 plan date
December 10, 2025
Pre-arranged trading plan governing the sales
Option expiration
April 7, 2035
Expiration date of the exercised stock option grant
Key Terms
Rule 10b5-1 trading plan, open-market sale, Stock Option (Right to Buy), Exercise or conversion of derivative security, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open-market sale financial
"transaction_action: "open-market sale" with transaction code "S""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" for the derivative transaction"
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security" for code "M""
vesting financial
"shares underlying this stock option vested on April 8, 2026, with the remainder vesting in thirty-six equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Kymera (KYMR) Chief Business Officer report?
Kymera’s Chief Business Officer Noah Goodman reported exercising options for 5,000 shares and selling 5,000 shares of Common Stock in open-market transactions. These trades combined an option exercise with share sales on the same date.
What stock options did the Kymera (KYMR) CBO exercise in this Form 4?
He exercised stock options covering 5,000 shares of Kymera Common Stock at an exercise price of $21.05 per share. These options are part of a larger grant with 25% vesting on April 8, 2026 and the remainder vesting monthly thereafter.
Were the Kymera (KYMR) insider stock sales under a Rule 10b5-1 plan?
Yes. The filing states the transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025. Such pre-arranged plans automate trades over time, reducing the significance of short-term market timing for these sales.
AI-generated analysis. How Rhea-AI works. Not financial advice.
